Skip to main content

LVW Advisors, LLC

SEC CIK
0001576053
Latest filing
Jul 15, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by LVW Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
8,382
Value
$401.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by LVW Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,382$401.8K<0.1%−2,548−23.3%ReducedHolders
Q1 202610,930$401.7K<0.1%+1,447+15.3%AddedHolders
Q4 20259,483$482.5K<0.1%−4,125−30.3%ReducedHolders
Q3 202513,608$755.1K0.1%−268−1.9%ReducedHolders
Q2 202513,876$957.7K0.1%−1,422−9.3%ReducedHolders
Q1 202515,298$1.06M0.1%+1,145+8.1%AddedHolders
Q4 202414,153$1.22M0.1%−1,091−7.2%ReducedHolders
Q3 202415,244$1.82M0.2%−1,397−8.4%ReducedHolders
Q2 202416,641$2.38M0.3%+223+1.4%AddedHolders
Q1 202416,418$2.11M0.4%−624−3.7%ReducedHolders
Q4 202317,042$1.76M0.3%−710−4.0%ReducedHolders
Q3 202317,752$1.61M0.3%−5,138−22.4%ReducedConverted for a 2-for-1 splitHolders
Q2 202311,445$1.85M0.4%−347−2.9%ReducedHolders
Q1 202311,792$1.88M0.4%+126+1.1%AddedHolders
Q4 202211,666$1.58M0.3%−1,925−14.2%ReducedHolders
Q3 202213,591$1.35M0.3%−617−4.3%ReducedHolders
Q2 202214,208$1.58M0.3%+2,004+16.4%AddedHolders
Q1 202212,204$1.35M0.2%−4,556−27.2%ReducedHolders
Q4 202116,760$1.88M0.3%−587−3.4%ReducedHolders
Q3 202117,347$1.67M0.3%−252−1.4%ReducedHolders
Q2 202117,599$1.47M0.3%−43−0.2%ReducedHolders
Q1 202117,642$1.19M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.